PLP treatment ameliorated colitis in IL-10−/− mice due to a reduction in colonic TNFα, IL-6, IFNγ, COX-2 and nitric oxide synthase (iNOS) expression and modulation of the chemotactic lipid S1P (240). Here, IL6 is linked to colitis.